Updated FDA Guidance on Continuous Manufacturing of Drug Substances and Drug Products
Full FDA guidance on Q13 Continuous Manufacturing available for download
Full FDA guidance on Q13 Continuous Manufacturing available for download
Just – Evotec Biologics’ 2022 Highlights
Read the article about how to rapidly develop and manufacture mAb-based therapeutics
Read the interview with Randal Bass, EVP Process Design & Biotherapeutic Operations at Just-Evotec Biologics
Read the article describing the latest trends in the biopharmaceutical industry
Read the article on our continuous bioprocess platform used at J.POD
Read the article about how to rapidly develop and manufacture mAb-based therapeutics
Read the article on why early mAb optimization might be right for your project.
Read the article on our continuous manufacturing technologies used in our cGMP manufacturing facility J.POD.
Read the article on our cGMP manufacturing facility J.POD in the June edition of BioProcess Int.
In recent years, the multi-attribute method (MAM) has become an important mass spectrometry-based tool for identifying and quantifying the site-specific product attributes and purity information…
Current methods for stably expressing biotherapeutics in CHO cells often rely on random or semi-random integration events which result in widely heterogeneous cell populations. In…